{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:50:19Z","timestamp":1789023019192,"version":"build-2803163510"},"reference-count":390,"publisher":"Elsevier","isbn-type":[{"value":"9780443294143","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["JKST&IC SRE\/160-64"],"award-info":[{"award-number":["JKST&IC SRE\/160-64"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apcsb.2025.08.017","type":"book-chapter","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:11:53Z","timestamp":1757106713000},"page":"379-453","source":"Crossref","is-referenced-by-count":4,"title":["Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook"],"prefix":"10.1016","member":"78","reference":[{"issue":"5943","key":"10.1016\/bs.apcsb.2025.08.017_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide y distribution in human brain","volume":"306","author":"Adrian","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1871527322666230306085937","article-title":"Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation","volume":"23","author":"Ahanger","year":"2024","journal-title":"CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders)"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636454","article-title":"Rationalizing the role of monosodium glutamate in the protein aggregation through biophysical approaches: Potential impact on neurodegeneration","volume":"15","author":"Ahanger","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib4","series-title":"Cellular osmolytes: From chaperoning protein folding to clinical perspectives","first-page":"161","article-title":"Diverse biological functions of myo-inositol: A neuro-metabolite, osmoprotectant, and diagnostic marker","author":"Ahanger","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102538","article-title":"Small molecule modulators of alpha-uclein aggregation and toxicity: Pioneering an emerging arsenal against Parkinson\u2019s disease","author":"Ahanger","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/bs.pmbts.2024.10.006","article-title":"Modulation of conformational integrity and aggregation propensity of \u03b1-uclein by osmolytes: Implications in therapeutic intervention of Parkinson\u2019s disease","author":"Ahanger","year":"2025","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsomega.0c05638","article-title":"Heparin accelerates the protein aggregation via the downhill polymerization mechanism: Multi-spectroscopic studies to delineate the implications on proteinopathies","volume":"6","author":"Ahanger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134714","article-title":"Counteraction of the cetyltrimethylammonium bromide-induced protein aggregation by heparin: Potential impact on protein aggregation and neurodegenerative diseases using biophysical approaches","volume":"1276","author":"Ahanger","year":"2023","journal-title":"Journal of Molecular Structure"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib9","series-title":"Autism spectrum disorder and Alzheimer\u2019s disease: Advances in research","first-page":"43","article-title":"The pathogenesis and complications associated with autism spectrum disorder and Alzheimer\u2019s disease: A comparative study","author":"Ahanger","year":"2022"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141054","article-title":"Neurometabolite, myo-inositol, induces conformational distortion with enhanced aggregation of carbonic anhydrase: Implications for altered metabolite levels in Alzheimer\u2019s disease","volume":"1325","author":"Ahanger","year":"2025","journal-title":"Journal of Molecular Structure"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-Synuclein oligomers and fibrils: A spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib12","doi-asserted-by":"crossref","DOI":"10.4161\/idp.26255","article-title":"Biophysical characterization of \u03b1-synuclein and its controversial structure","volume":"1","author":"Alderson","year":"2013","journal-title":"Intrinsically Disordered Proteins"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2010.05.026","article-title":"Neurodegenerative models in drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis","volume":"40","author":"Ambegaokar","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib15","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1038\/s41467-022-32797-w","article-title":"The clinical drug candidate anle138b binds in a cavity of lipidic \u03b1-uclein fibrils","volume":"13","author":"Antonschmidt","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib16","series-title":"Alpha-synuclein and uceinopathies as related to Parkinson\u2019s disease","author":"Anyanwu","year":"2017"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib17","series-title":"Biophysical studies of the alpha-synuclein protein associated with Parkinson\u2019s disease and other ucleinopathies","author":"Apetri","year":"2006"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib18","doi-asserted-by":"crossref","unstructured":"Appel-Cresswell, S., Vilarino-Guell, C., Yu, I., Shah, B., Weir, D., Thompson, C., & Farrer, M. (2012). Alpha-synuclein H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Paper presented at the Movement disorders.","DOI":"10.1002\/mds.25421"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0452-6","article-title":"Mechanisms underlying extensive Ser129-phosphorylation in \u03b1-synuclein aggregates","volume":"5","author":"Arawaka","year":"2017","journal-title":"Acta Neuropathologica Communications"},{"issue":"49","key":"10.1016\/bs.apcsb.2025.08.017_bib20","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1021\/acs.jafc.5b03882","article-title":"Solution structure of enterocin HF, an listerial bacteriocin produced by enterococcus faecium M3K31","volume":"63","author":"Arbulu","year":"2015","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"24","key":"10.1016\/bs.apcsb.2025.08.017_bib21","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.3390\/ijms222413398","article-title":"Ellagic acid prevents \u03b1-synuclein aggregation and protects sh-sy5y cells from aggregated \u03b1-synuclein-induced toxicity via suppression of apoptosis and activation of autophagy","volume":"22","author":"Ardah","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15472-4","article-title":"Bivalent metal ions induce formation of \u03b1-synuclein fibril polymorphs with different cytotoxicities","volume":"12","author":"Atarod","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib23","unstructured":"Auli\u0107, S. (2015). Alpha-synuclein amyloid accumulation and its interaction with prion protein."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2024.100163","article-title":"Novel approaches targeting in \u03b1-synuclein for Parkinson\u2019s disease: Current progress and future directions for the disease-modifying therapies","author":"Baggett","year":"2024","journal-title":"Brain Disorders"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2014.01.039","article-title":"Pesticides exposure as etiological factors of Parkinson\u2019s disease and other neurodegenerative diseases\u2014a mechanistic approach","volume":"230","author":"Baltazar","year":"2014","journal-title":"Toxicology Letters"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/9781119155195.ch26","article-title":"Effect of polyphenols on protein misfolding","author":"Banerjee","year":"2017","journal-title":"Neuroprotective Effects of Phytochemicals in Neurological Disorders"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib27","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophysical Journal"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cbic.200900666","article-title":"Strategies for the inhibition of protein aggregation in human diseases","volume":"11","author":"Bartolini","year":"2010","journal-title":"Chembiochem: a European Journal of Chemical Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27949","article-title":"Probing protein aggregation through spectroscopic insights and multimodal approaches: A comprehensive review for counteracting neurodegenerative disorders","author":"Bashir","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib30","unstructured":"Basu, S. (2017). Implication of alpha-synuclein transcriptional regulation and mutagenesis in the pathogenesis of sporadic Parkinson\u2019s disease."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107742","article-title":"Alpha-synuclein, autophagy-lysosomal pathway, and lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions","author":"Bayati","year":"2024","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.661117","article-title":"Modulation of the interactions between \u03b1-synuclein and lipid membranes by post-translational modifications","volume":"12","author":"Bell","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2016.08.008","article-title":"From the evolution of protein sequences able to resist self-assembly to the prediction of aggregation propensity","volume":"329","author":"Bemporad","year":"2017","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib34","unstructured":"Betts, J. G., Young, K. A., Wise, J. A., Johnson, E., Poe, B., Kruse, D. H., & DeSaix, P. (2024). Anatomy and physiology 2e."},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib35","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/biomedicines10092055","article-title":"Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics","volume":"10","author":"Bhalani","year":"2022","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.017_bib36","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"30","key":"10.1016\/bs.apcsb.2025.08.017_bib37","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1021\/ja0618649","article-title":"Interaction of \u03b1-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement","volume":"128","author":"Binolfi","year":"2006","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.666585","article-title":"\u03b1-Synuclein: An all-inclusive trip around its structure, influencing factors and applied techniques","volume":"9","author":"Bisi","year":"2021","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","article-title":"Plasma alpha-synuclein levels in patients with Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"40","author":"Bougea","year":"2019","journal-title":"Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib40","doi-asserted-by":"crossref","first-page":"214a","DOI":"10.1016\/j.bpj.2023.11.1363","article-title":"Structural and functional characterization of N-terminally acetylated \u03b1-synuclein","volume":"123","author":"Brackhahn","year":"2024","journal-title":"Biophysical Journal"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib41","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170007","article-title":"Control of mitochondrial biogenesis and function by the ubiquitin\u2013proteasome system","volume":"7","author":"Bragoszewski","year":"2017","journal-title":"Open Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/1567205014666170206163158","article-title":"Molecular targets of tannic acid in Alzheimer\u2019s disease","volume":"14","author":"Braidy","year":"2017","journal-title":"Current Alzheimer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u03b1-Synuclein misfolding and Parkinson\u2019s disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-synuclein induced aptopathy in Parkinson\u2019s disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib46","first-page":"1","article-title":"Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies)","volume":"46","author":"Brown","year":"2008","journal-title":"Folia Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib47","unstructured":"Bucolo, F. (2023). Computational and synthetic approaches for the development of new agents in the management of oncological and neurodegenerative diseases."},{"issue":"40","key":"10.1016\/bs.apcsb.2025.08.017_bib48","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib49","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5999","key":"10.1016\/bs.apcsb.2025.08.017_bib50","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science (New York, N. Y.)"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other ucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib52","first-page":"129","article-title":"Fourier transform infrared and circular dichroism spectroscopies for amyloid studies","author":"Calero","year":"2005","journal-title":"Amyloid Proteins: Methods and Protocols"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","article-title":"Calcium signaling in Parkinson\u2019s disease","volume":"357","author":"Cal\u00ec","year":"2014","journal-title":"Cell Tissue Research"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/bs.pmbts.2019.12.008","article-title":"Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation","volume":"170","author":"Cao","year":"2020","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib55","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.3390\/ijms22126517","article-title":"Alpha-synuclein as a prominent actor in the inflammatory aptopathy of parkinson\u2019s disease","volume":"22","author":"Cardinale","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib56","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/antiox9020149","article-title":"Potential protective role exerted by secoiridoids from olea europaea L. In cancer, cardiovascular, neurodegenerative, aging-related, and immunoinflammatory diseases","volume":"9","author":"Castej\u00f3n","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s42003-021-02026-z","article-title":"Conformational distortion in a fibril-forming oligomer arrests alpha-synuclein fibrillation and minimizes its toxic effects","volume":"4","author":"Chakraborty","year":"2021","journal-title":"Communications Biology"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.08.017_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172192","article-title":"Gut mucosal cells transfer \u03b1-synuclein to the vagus nerve","volume":"8","author":"Chandra","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110133","article-title":"Dopaminergic system and neurons: Role in multiple neurological diseases","author":"Chen","year":"2024","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib61","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1074\/jbc.M110.177246","article-title":"Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-\u03b2 stability, oligomerization, and aggregation: Amyloid-\u03b2 destabilization promotes annular protofibril formation","volume":"286","author":"Chen","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib62","first-page":"1","article-title":"Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and \u0251-synuclein in caenorhabditis elegans models","author":"Chen","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchemneu.2010.12.001","article-title":"The role of alpha-synuclein in neurotransmission and synaptic plasticity","volume":"42","author":"Cheng","year":"2011","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.017_bib65","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1111\/febs.14587","article-title":"Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"285","author":"Choi","year":"2018","journal-title":"The FEBS Journal"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2174\/1871527313666140917121943","article-title":"Ignored avenues in alpha-synuclein associated proteopathy","volume":"13","author":"Chowhan","year":"2014","journal-title":"CNS Neurological Disorders-Drug Targets"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-81-322-2467-9_8","article-title":"Proteopathies: Biological, molecular and clinical perspectives","author":"Chowhan","year":"2015","journal-title":"Proteostasis Chaperone Surveillance"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The\u00a0synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson\u2019s disease linked \u03b1\u2010synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5545","key":"10.1016\/bs.apcsb.2025.08.017_bib70","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib71","doi-asserted-by":"crossref","first-page":"1430919","DOI":"10.3389\/fvets.2024.1430919","article-title":"Synthetic antimicrobial peptides Bac-5, BMAP-28, and Syn-1 can inhibit bovine respiratory disease pathogens in vitro","volume":"11","author":"Cornejo","year":"2024","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","article-title":"Structural characteristics of \u03b1-synuclein oligomers","volume":"329","author":"Cremades","year":"2017","journal-title":"International Review of Cell Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib73","series-title":"Premotor enteric nervous system impairment in an experimental Parkinson model","author":"da Silva","year":"2015"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2012.10.001","article-title":"Vitamins k interact with N-terminus \u03b1-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and \u03b1-synuclein","volume":"62","author":"da Silva","year":"2013","journal-title":"Neurochemistry International"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib75","first-page":"425","article-title":"Amino acids, peptides and proteins","volume":"4","author":"Damodaran","year":"2008","journal-title":"Fennema\u2019s Food Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib76","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/1570159X21666221221092250","article-title":"Neuroprotective role of quercetin against Alpha-synuclein-associated hallmarks in Parkinson\u2019s disease","volume":"21","author":"Das","year":"2023","journal-title":"Current Neuropharmacology"},{"issue":"16","key":"10.1016\/bs.apcsb.2025.08.017_bib77","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib79","unstructured":"De Franceschi, G. (2009). Alpha-synuclein and polyunsaturated fatty acids molecular characterization of the interaction and implication in protein aggregation."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib80","series-title":"Role of alpha-synuclein in neurodegeneration","author":"de Freitas Noronha","year":"2013"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxidants & Redox Signaling"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molmed.2013.04.002","article-title":"The remarkable conformational plasticity of alpha-synuclein: Blessing or curse?","volume":"19","author":"Deleersnijder","year":"2013","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21307\/PM-2019.58.1.019","article-title":"Cathelicidins in humans and animals","volume":"58","author":"Deptu\u0142a","year":"2019","journal-title":"Post\u0119py Mikrobiologii-Advancements of Microbiology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153049","article-title":"Environmental factors modulating protein conformations and their role in protein aggregation diseases","volume":"465","author":"Devi","year":"2022","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1871524920666200705222842","article-title":"Understanding the pathogenesis involved in Parkinson\u2019s disease and potential therapeutic treatment strategies","volume":"20","author":"Dhanawat","year":"2020","journal-title":"Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Central Nervous System Agents)"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib86","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cellular Molecular life Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib87","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib88","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neuro.2006.05.012","article-title":"Paraquat exposure as an etiological factor of Parkinson's disease","volume":"27","author":"Dinis-Oliveira","year":"2006","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pro.5560060117","article-title":"Structures of n\u2010termini of helices in proteins","volume":"6","author":"Doig","year":"1997","journal-title":"Protein Science"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib90","doi-asserted-by":"crossref","first-page":"146","DOI":"10.37398\/JSR.2021.650119","article-title":"The counteracting performance of phytoconstituents against neurodegeneration involved in Parkinson\u2019s","volume":"65","author":"Doke","year":"2021","journal-title":"Journal of Scientific Research"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib91","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/bi101912q","article-title":"Coordination features and affinity of the Cu2+ site in the \u03b1-synuclein protein of Parkinson\u2019s disease","volume":"50","author":"Dudzik","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fimmu.2013.00143","article-title":"The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds","volume":"4","author":"Duplantier","year":"2013","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105966","article-title":"Monitoring \u03b1-synuclein aggregation","volume":"176","author":"Estaun-Panzano","year":"2023","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109213","article-title":"Removal of proteinase k resistant \u03b1Syn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model","volume":"218","author":"Etel\u00e4inen","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib95","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00018-007-7110-2","article-title":"On the structural definition of amyloid fibrils and other polypeptide aggregates","volume":"64","author":"F\u00e4ndrich","year":"2007","journal-title":"Cellular Molecular Life Sciences"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.017_bib96","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1239009","article-title":"Nicotine-mediated effects in neuronal and mouse models of\u00a0synucleinopathy","volume":"17","author":"Fares","year":"2023","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s42003-022-03059-8","article-title":"The C-terminal tail of \u03b1-synuclein protects against aggregate replication but is critical for oligomerization","volume":"5","author":"Farzadfard","year":"2022","journal-title":"Communications Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnbeh.2016.00121","article-title":"Dopamine replacement therapy, learning and reward prediction in Parkinson\u2019s disease: Implications for rehabilitation","volume":"10","author":"Ferrazzoli","year":"2016","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of \u03b1-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Accounts of Chemical Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib101","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13311-017-0515-1","article-title":"Focused ultrasound: An emerging therapeutic modality for neurologic disease","volume":"14","author":"Fishman","year":"2017","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib102","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.3390\/ijms24065914","article-title":"Alpha\u00a0synuclein: Neurodegeneration and inflammation","volume":"24","author":"Forloni","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib103","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib104","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biochi.2021.09.012","article-title":"Neurotoxic or neuroprotective: Post-translational modifications of \u03b1-synuclein at the cross-roads of functions","volume":"192","author":"Gadhavi","year":"2022","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: Clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib106","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/molecules28052212","article-title":"Supersaturation and precipitation applicated in drug delivery systems: Development strategies and evaluation approaches","volume":"28","author":"Gan","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0257-4","article-title":"Altered machinery of protein synthesis is region-and stage-dependent and is associated with \u03b1-synuclein oligomers in Parkinson\u2019s disease","volume":"3","author":"Garcia-Esparcia","year":"2015","journal-title":"Acta Neuropathologica Communications"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib108","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1289\/ehp.0900852","article-title":"Well-water consumption and Parkinson\u2019s disease in rural california","volume":"117","author":"Gatto","year":"2009","journal-title":"Environmental Health Perspectives"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-201549","article-title":"Polyphenol-peptide interactions in mitigation of Alzheimer\u2019s disease: Role of biosurface-induced aggregation","volume":"81","author":"Gaudreault","year":"2021","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib110","first-page":"1","article-title":"The\u00a0synucleins","volume":"3","author":"George","year":"2001","journal-title":"Journal Genome Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib111","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s000180050328","article-title":"SNAREs and SNARE regulators in membrane fusion and exocytosis","volume":"55","author":"Gerst","year":"1999","journal-title":"Cellular Molecular Life Sciences CMLS"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Progress in Neurobiology"},{"issue":"368","key":"10.1016\/bs.apcsb.2025.08.017_bib113","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2210","article-title":"Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson\u2019s disease","volume":"8","author":"Ghosh","year":"2016","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","article-title":"\u03b1-Synuclein aggregation and its modulation","volume":"100","author":"Ghosh","year":"2017","journal-title":"International Journal of Biological Macromolecules"},{"issue":"40","key":"10.1016\/bs.apcsb.2025.08.017_bib115","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1021\/bi400999d","article-title":"The Parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-synuclein aggregation in vitro","volume":"52","author":"Ghosh","year":"2013","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib116","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1038\/srep09228","article-title":"Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-Synuclein aggregation","volume":"5","author":"Ghosh","year":"2015","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib117","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib118","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870060103","article-title":"Neuronal inclusions of Parkinson's disease","volume":"6","author":"Gibb","year":"1991","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0176-9","article-title":"Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease","volume":"2","author":"Gir\u00e1ldez-P\u00e9rez","year":"2014","journal-title":"Acta Neuropathologica Communications"},{"issue":"28","key":"10.1016\/bs.apcsb.2025.08.017_bib120","doi-asserted-by":"crossref","first-page":"19182","DOI":"10.1039\/D3CP02261G","article-title":"How oxidized EGCG remodels \u03b1-synuclein fibrils into non-toxic aggregates: Insights from computational simulations","volume":"25","author":"Gon\u00e7alves","year":"2023","journal-title":"Physical Chemistry Chemical Physics"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib121","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2010.115","article-title":"In vivo RNAi-mediated \u03b1-synuclein silencing induces nigrostriatal degeneration","volume":"18","author":"Gorbatyuk","year":"2010","journal-title":"Molecular Therapy"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib122","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2174\/1389201025666230830125410","article-title":"Insights on quercetin therapeutic potential for neurodegenerative diseases and its nano-technological perspectives","volume":"25","author":"Goyal","year":"2024","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.08.017_bib123","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.3390\/ijms21218043","article-title":"Multiplicity of \u03b1-synuclein aggregated species and their possible roles in disease","volume":"21","author":"Gracia","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.6026\/973206300200217","article-title":"Molecular docking analysis of \u03b1-Synuclein aggregation with Anle138b","volume":"20","author":"Grewal","year":"2024","journal-title":"Bioinformation"},{"issue":"42","key":"10.1016\/bs.apcsb.2025.08.017_bib125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012832","article-title":"A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant acinetobacter baumannii by interacting with outer membrane protein a (OmpA)","volume":"97","author":"Guo","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20150617","article-title":"Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease","volume":"471","author":"Gustot","year":"2015","journal-title":"Biochemical Journal"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib127","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/biomedicines10071743","article-title":"Synaptic disruption by soluble oligomers in patients with Alzheimer\u2019s and Parkinson\u2019s disease","volume":"10","author":"Gutierrez","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"Curcumin and Alzheimer's disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2023.100334","article-title":"Dietary flavonoids: Promising compounds for targeting \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"24","author":"Harati","year":"2023","journal-title":"PharmaNutrition"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.14802\/jmd.24075","article-title":"\u03b1-Synuclein: A promising biomarker for Parkinson\u2019s disease and related disorders","volume":"17","author":"Hatano","year":"2024","journal-title":"Journal of Movement Disorders"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib131","doi-asserted-by":"crossref","unstructured":"Hejjaoui, M. (2012). Elucidating the role of post-translational modifications of alpha-synuclein using semisynthesis: Phosphorylation at Tyrosine 125 and monoubiquitination at lysine 6. Retrieved from.","DOI":"10.1021\/ja210866j"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.017_bib132","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acschemneuro.0c00381","article-title":"Potential role of natural polyphenols against protein aggregation toxicity: In vitro, in vivo, and clinical studies","volume":"11","author":"Henr\u00edquez","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib133","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41598-021-04131-9","article-title":"Two-step screening method to identify \u03b1-synuclein aggregation inhibitors for Parkinson\u2019s disease","volume":"12","author":"Hideshima","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib134","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0330-20.2020","article-title":"\u03b1-Synuclein aggregates increase the conductance of substantia nigra dopamine neurons, an effect partly reversed by the KATP channel inhibitor glibenclamide","volume":"8","author":"Hill","year":"2021","journal-title":"Eneuro"},{"issue":"46","key":"10.1016\/bs.apcsb.2025.08.017_bib135","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of \u03b1-synuclein tyrosine nitration: Diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.017_bib136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/DMR-120001387","article-title":"Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes","volume":"34","author":"Hollenberg","year":"2002","journal-title":"Drug Metabolism Reviews"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib137","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/092986611794578332","article-title":"Characterization of the non-fibrillar \u03b1-synuclein oligomers","volume":"18","author":"Hong","year":"2011","journal-title":"Protein and Peptide Letters"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib138","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.fct.2018.06.059","article-title":"Protective effects of hydroxytyrosol against \u03b1-synuclein toxicity on PC12 cells and fibril formation","volume":"120","author":"Hornedo-Ortega","year":"2018","journal-title":"Food and Chemical Toxicology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib139","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4103\/1673-5374.387987","article-title":"Hydroxytyrosol and Parkinson's disease: Protective actions against alpha-synuclein toxicity","volume":"19","author":"Hornedo-Ortega","year":"2024","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib140","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopha.2017.10.050","article-title":"Ginkgolide b and bilobalide ameliorate neural cell apoptosis in \u03b1-synuclein aggregates","volume":"96","author":"Hua","year":"2017","journal-title":"Biomedicine Pharmacotherapy"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib141","article-title":"Nicotine ameliorates \u03b1-synuclein pre-formed fibril-induced behavioral deficits and pathological features in mice","author":"Huang","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib142","series-title":"Linking the structure of alpha-synuclein oligmers to function in Parkinson's disease","author":"Illes-Toth","year":"2013"},{"issue":"39","key":"10.1016\/bs.apcsb.2025.08.017_bib143","doi-asserted-by":"crossref","first-page":"20537","DOI":"10.1021\/acs.langmuir.4c02178","article-title":"Salt-Induced hydrophobic C-Terminal region of \u03b1-synuclein triggers its fibrillation under the mimic physiologic condition","volume":"40","author":"Imaura","year":"2024","journal-title":"Langmuir: the ACS Journal of Surfaces and Colloids"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/157015907780866893","article-title":"Parkinson's disease: Genetics and beyond","volume":"5","author":"Inamdar","year":"2007","journal-title":"Current Neuropharmacology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib145","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib146","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/brb3.86","article-title":"Role of c\u2010terminal negative charges and tyrosine residues in fibril formation of \u03b1\u2010synuclein","volume":"2","author":"Izawa","year":"2012","journal-title":"Brain Behavior"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140951","article-title":"Effect of flavonoids on the destabilization of \u03b1-synuclein fibrils and their conversion to amorphous aggregate: A molecular dynamics simulation and experimental study","volume":"1871","author":"Jahan","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib148","article-title":"Check for pathophysiology and management approaches in Alzheimer's disease shreshta jain, divya goel, sheikh sana nazir, vaishali yadav, and divya vohora","volume":"77","author":"Jain","year":"2023","journal-title":"Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib149","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"Journal of Neurology, Neurosurgery Psychiatry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib150","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3389\/fphar.2018.01555","article-title":"Plant extracts and phytochemicals targeting \u03b1-synuclein aggregation in Parkinson's disease models","volume":"9","author":"Javed","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib151","first-page":"270","article-title":"Formation and development of lewy pathology: A critical update","volume":"256","author":"Jellinger","year":"2009","journal-title":"Journal of Neurology, Neurosurgery Psychiatry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/srep28511","article-title":"Effect of curcumin analogs on\u03b1-synuclein aggregation and cytotoxicity","volume":"6","author":"Jha","year":"2016","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib153","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/acs.biochem.7b01090","article-title":"Complexation of NAC-derived peptide ligands with the C-terminus of \u03b1-synuclein accelerates its aggregation","volume":"57","author":"Jha","year":"2018","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib154","first-page":"759","article-title":"Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing","volume":"57","author":"Ji","year":"1997","journal-title":"Cancer Research"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.08.017_bib155","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.3390\/ijms252212380","article-title":"Co-aggregation of TDP-43 with other pathogenic proteins and their Co-pathologies in neurodegenerative diseases","volume":"25","author":"Jiang","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.08.017_bib156","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2174\/1389557523666230517163501","article-title":"Research progress of \u03b1-synuclein aggregation inhibitors for potential Parkinson\u2019s disease treatment","volume":"23","author":"Kalsoom","year":"2023","journal-title":"Mini Reviews in Medicinal Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib157","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","article-title":"Nicotine slows down oligomerisation of \u03b1-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease","volume":"1863","author":"Kardani","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102113","article-title":"Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: Insights from clinical trials","author":"Khan","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib159","doi-asserted-by":"crossref","first-page":"281","DOI":"10.37349\/ent.2023.00052","article-title":"The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson\u2019s disease","volume":"3","author":"Khan","year":"2023","journal-title":"Exploration of Neuroprotective Therapy"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102579","article-title":"Multifaceted interactions mediated by intrinsically disordered regions play key roles in alpha\u00a0synuclein aggregation","volume":"80","author":"Khare","year":"2023","journal-title":"Current Opinion in Structural Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0113895575306884240604065754","article-title":"A review of the protective effects of alkaloids against alpha-synuclein toxicity in Parkinson\u2019s disease","volume":"25","author":"Khodadadi","year":"2025","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib162","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s12035-016-0370-9","article-title":"Alpha-synuclein suppresses retinoic acid-induced neuronal differentiation by targeting the glycogen synthase kinase-3\u03b2\/\u03b2-catenin signaling pathway","volume":"55","author":"Kim","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib163","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jmb.2006.05.004","article-title":"A novel mechanism of interaction between \u03b1-synuclein and biological membranes","volume":"360","author":"Kim","year":"2006","journal-title":"Journal of Molecular Biology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.08.017_bib164","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","article-title":"Brain stem pathology in Parkinson's disease: An evaluation of the braak staging model","volume":"25","author":"Kingsbury","year":"2010","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib166","series-title":"Garner and Klintworth's pathobiology of ocular disease","first-page":"956","article-title":"Amyloidoses","author":"Klintworth","year":"2008"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib167","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib168","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/NEN.0b013e31818c3618","article-title":"Aggregates assembled from overexpression of wild-type \u03b1-synuclein are not toxic to human neuronal cells","volume":"67","author":"Ko","year":"2008","journal-title":"Journal of Neuropathology Experimental Neurology"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.017_bib169","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.3390\/ijms25179197","article-title":"The role of \u03b1-synuclein in etiology of neurodegenerative diseases","volume":"25","author":"Krawczuk","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala 30 pro mutation in the gene encoding \u03b1\u00a0synuclein in Parkinson disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nature Genetics"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib171","first-page":"1954","article-title":"Interaction of proteins involved in neuronal proteinopathies","volume":"13","author":"Kulichikhin","year":"2023","journal-title":"Life (Chicago, Ill.: 1978)"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib172","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acschemneuro.1c00001","article-title":"Ellagic acid inhibits \u03b1-synuclein aggregation at multiple stages and reduces its cytotoxicity","volume":"12","author":"Kumar","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib173","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41593-023-01341-4","article-title":"Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage","volume":"26","author":"Kumar","year":"2023","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cger.2009.12.006","article-title":"Healthy brain aging: Effect of head injury, alcohol and environmental toxins","volume":"26","author":"Kumar","year":"2010","journal-title":"Clinics in Geriatric Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1353-8020(01)00054-2","article-title":"Occupational and environmental risk factors for Parkinson's disease","volume":"8","author":"Lai","year":"2002","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib176","series-title":"Structure and function of plasma proteins: Volume 2","first-page":"53","article-title":"Transferrin","author":"Lane","year":"1976"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.08.017_bib177","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"\u03b1-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease","volume":"21","author":"Lastres-Becker","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib178","series-title":"Strains of self-propagating protein aggregates in human neurodegenerative disease","author":"Lau","year":"2022"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib179","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gr.8.9.871","article-title":"The\u00a0synuclein family","volume":"8","author":"Lavedan","year":"1998","journal-title":"Genome Research"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib181","unstructured":"Le, T.T.N. (2014). From misfolded recombinant proteins in vitro to pathological agents in vivo."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00217-y","article-title":"Targeting \u03b1-synuclein by PD03 AFFITOPE\u00ae and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: Clinical relevance","volume":"9","author":"Lemos","year":"2020","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib183","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1\u2010synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib184","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmb.2011.05.046","article-title":"Conserved C-terminal charge exerts a profound influence on the aggregation rate of \u03b1-synuclein","volume":"411","author":"Levitan","year":"2011","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib185","series-title":"Cryo-EM structures and biological study of pathogenic alpha-synuclein fibrils","author":"Li","year":"2020"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.08.017_bib186","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1111\/j.1742-4658.2005.04792.x","article-title":"Inhibition of \u03b1\u2010synuclein fibrillization by dopamine analogs via reaction with the amino groups of \u03b1\u2010synuclein: Implication for dopaminergic neurodegeneration","volume":"272","author":"Li","year":"2005","journal-title":"The FEBS Journal"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib187","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1039\/D1NP00042J","article-title":"Squalamine and trodusquemine: Two natural products for neurodegenerative diseases, from physical chemistry to the clinic","volume":"39","author":"Limbocker","year":"2022","journal-title":"Natural Product Reports"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.017_bib188","doi-asserted-by":"crossref","first-page":"14558","DOI":"10.1074\/jbc.M700422200","article-title":"Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated \u03b1-synuclein implies lewy body biogenesis","volume":"282","author":"Liu","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib189","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2015.12.002","article-title":"Fasudil, a rho kinase inhibitor, promotes the autophagic degradation of A53T \u03b1-synuclein by activating the JNK 1\/Bcl-2\/beclin 1 pathway","volume":"1632","author":"Liu","year":"2016","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1039\/D1NP00026H","article-title":"Structure, synthesis, biosynthesis, and activity of the characteristic compounds from ginkgo biloba l","volume":"39","author":"Liu","year":"2022","journal-title":"Natural Product Reports"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib191","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1080\/07391102.2020.1858165","article-title":"Biflavonoids from rhus succedanea as probable natural inhibitors against SARS-CoV-2: A molecular docking and molecular dynamics approach","volume":"40","author":"Lokhande","year":"2022","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib192","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1039\/D2NP00087C","article-title":"Polyamine-containing natural products: Structure, bioactivity, and biosynthesis","volume":"41","author":"Long","year":"2024","journal-title":"Natural Product Reports"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib193","series-title":"Effects of systemic viral gene therapy on enteric neurons: Relevance to Parkinson\u2019s disease","author":"Lopez","year":"2024"},{"issue":"31","key":"10.1016\/bs.apcsb.2025.08.017_bib194","doi-asserted-by":"crossref","first-page":"21299","DOI":"10.1074\/jbc.M114.554667","article-title":"How epigallocatechin gallate can inhibit \u03b1-synuclein oligomer toxicity in vitro\u2666","volume":"289","author":"Lorenzen","year":"2014","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fnins.2019.00552","article-title":"Prion-like mechanisms in Parkinson\u2019s disease","volume":"13","author":"Ma","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib196","series-title":"Studies on the mechanism of alpha-synuclein aggregation in lewy body disease","author":"Madine","year":"2006"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib197","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijbiomac.2022.11.038","article-title":"An investigation into the potential action of polyphenols against human islet amyloid polypeptide aggregation in type 2 diabetes","volume":"225","author":"Mahboob","year":"2023","journal-title":"International Journal of Biological Macromolecules"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib198","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/cdd.2015.79","article-title":"Fibril growth and seeding capacity play key roles in \u03b1-synuclein-mediated apoptotic cell death","volume":"22","author":"Mahul-Mellier","year":"2015","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib199","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-030-24285-5_7","article-title":"Dysregulation of heat shock proteins in neurodegenerative diseases: Restorative roles of small molecules and natural compounds","author":"Maiti","year":"2019","journal-title":"Heat Shock Proteins in Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cne.21160","article-title":"Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase\u20101 transgenic mice: Mechanisms of mitochondriopathy and cell death","volume":"500","author":"Martin","year":"2007","journal-title":"Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/10409238.2023.2201406","article-title":"Protein aggregation-inhibition: A therapeutic route from Parkinson\u2019s disease to sickle cell anemia","volume":"58","author":"Martins","year":"2023","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.08.017_bib202","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214652120","article-title":"Phosphorylation of \u03b1-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson\u2019s disease","volume":"120","author":"Matsui","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116176","article-title":"Inhibitory effect of naturally occurring ocimum sanctum extract on \u03b1-Synuclein aggregation in aqueous solution","volume":"336","author":"Meena","year":"2021","journal-title":"Journal of Molecular Liquids"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib204","series-title":"Investigation of small molecules as modulators of \u03b1-synuclein aggregation; relevance to Parkinson\u2019s disease","author":"Meena","year":"2021"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib205","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/biom11101419","article-title":"Structural and functional insights into \u03b1-synuclein fibril polymorphism","volume":"11","author":"Mehra","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib206","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"34","key":"10.1016\/bs.apcsb.2025.08.017_bib207","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1021\/bi900506b","article-title":"Molecular mechanisms underlying the flavonoid-induced inhibition of \u03b1-synuclein fibrillation","volume":"48","author":"Meng","year":"2009","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib208","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1432-1033.1984.tb08607.x","article-title":"Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins","volume":"145","author":"Metz\u2010Boutigue","year":"1984","journal-title":"European Journal of Biochemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib209","first-page":"4005","article-title":"The role of probiotics in Parkinson's disease: A review study","volume":"11","author":"Mh Mubarak","year":"2021","journal-title":"Journal of Advanced Biomedical Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib210","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of \u03b1\u2010synuclein by calpain I in vitro","volume":"86","author":"Mishizen\u2010Eberz","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib211","article-title":"Neuroprotective effect of naturally occurring flavonoids","author":"Mishra","year":"2024","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"issue":"35","key":"10.1016\/bs.apcsb.2025.08.017_bib212","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1021\/acs.biochem.8b00314","article-title":"Comparison of kinetics, toxicity, oligomer formation, and membrane binding capacity of \u03b1-synuclein familial mutations at the A53 site, including the newly discovered A53V mutation","volume":"57","author":"Mohite","year":"2018","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib213","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"24","author":"Moon","year":"2015","journal-title":"Experimental Neurobiology"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.08.017_bib214","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.3390\/ijms21217884","article-title":"Effects of detergent on \u03b1-synuclein structure: A native MS-Ion mobility study","volume":"21","author":"Moons","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson\u2019s disease","volume":"6","author":"Mosley","year":"2006","journal-title":"Clinical Neuroscience Research"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib216","unstructured":"Moualla, D. (2011). The role of alpha synuclein in Parkinson's disease."},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib217","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.NME.0000520138.79348.8c","article-title":"Dive into deep brain stimulation","volume":"15","author":"Murphy","year":"2017","journal-title":"Nursing Made Incredibly Easy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib218","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","article-title":"Curcumin: A potential neuroprotective agent in Parkinson's disease","volume":"18","author":"Mythri","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166878","article-title":"Brazilin removes toxic alpha-synuclein and seeding competent assemblies from Parkinson brain by altering conformational equilibrium","volume":"433","author":"Nahass","year":"2021","journal-title":"Journal of Molecular Biology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib220","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1871527320666210208125912","article-title":"Drosophila melanogaster a versatile model of Parkinson\u2019s disease","volume":"20","author":"Naz","year":"2021","journal-title":"CNS Neurological Disorders-Drug Targets"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105760","article-title":"The misfolding mystery: \u03b1-syn and the pathogenesis of Parkinson's disease","author":"Negi","year":"2024","journal-title":"Neurochemistry International"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib222","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2217\/fmb.10.35","article-title":"Probiotic properties of lactobacillus salivarius and closely related lactobacillus species","volume":"5","author":"Neville","year":"2010","journal-title":"Future Microbiology"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.017_bib223","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/nu14183773","article-title":"Metabolism and bioavailability of olive bioactive constituents based on in vitro, in vivo and human studies","volume":"14","author":"Nikou","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib224","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-\u03b2","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib225","article-title":"Comparative studies in the A30P and A53T \u03b1-synuclein C. Elegans strains to investigate the molecular origins of Parkinson\u2019s disease","author":"Nishioka","year":"2021","journal-title":"Intracellular Mechanisms of \u03b1-Synuclein Processing"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib226","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/ijms25020986","article-title":"From synaptic physiology to synaptic pathology: The enigma of \u03b1-synuclein","volume":"25","author":"Nordengen","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib227","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/hmg\/6.10.1687","article-title":"Genetics of Parkinson\u2019s disease","volume":"6","author":"Nussbaum","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib228","author":"Odom","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib229","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/jasms.0c00463","article-title":"Conformational dynamics of \u03b1-synuclein during the interaction with phospholipid nanodiscs by millisecond hydrogen\u2013deuterium exchange mass spectrometry","volume":"32","author":"Oganesyan","year":"2021","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2019.01.045","article-title":"Toward the discovery and development of effective modulators of \u03b1-synuclein amyloid aggregation","volume":"167","author":"Oliveri","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib231","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.expneurol.2007.03.002","article-title":"Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of lewy body diseases","volume":"205","author":"Ono","year":"2007","journal-title":"Experimental Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib232","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/molecules25102444","article-title":"Anti-aggregation effects of phenolic compounds on \u03b1-synuclein","volume":"25","author":"Ono","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib233","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent\u00a0anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib234","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","article-title":"Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein: Implications for Parkinson\u2019s disease pathogenesis and therapies","volume":"183","author":"Oueslati","year":"2010","journal-title":"Progress in Brain Research"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006906","article-title":"Dopamine-induced conformational changes in alpha-synuclein","volume":"4","author":"Outeiro","year":"2009","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib236","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/abbi.2000.1822","article-title":"Metal-catalyzed oxidation of \u03b1-synuclein in the presence of copper (II) and hydrogen peroxide","volume":"378","author":"Paik","year":"2000","journal-title":"Archives of Biochemistry Biophysics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib237","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1038\/s41598-018-26645-5","article-title":"Oleuropein aglycone stabilizes the monomeric \u03b1-synuclein and favours the growth of non-toxic aggregates","volume":"8","author":"Palazzi","year":"2018","journal-title":"Scientific Reports"},{"issue":"24","key":"10.1016\/bs.apcsb.2025.08.017_bib238","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of \u03b1-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib239","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","article-title":"Curcumin inhibits aggregation of \u03b1-synuclein","volume":"115","author":"Pandey","year":"2008","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib240","series-title":"Cellular osmolytes: From chaperoning protein folding to clinical perspectives","first-page":"185","article-title":"Potential of osmolytes as diagnostic biomarkers in various diseases","author":"Parray","year":"2024"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib242","series-title":"Aggregation and conformation of alpha-synuclein: Effects of ligand binding and phosphomimetics","author":"Paskins","year":"2017"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib243","unstructured":"Patel, D., & Bordoni, B. (2020). Physiology, synuclein."},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib244","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/pharmaceutics15030839","article-title":"Development of small molecules targeting \u03b1-synuclein aggregation: A promising strategy to treat Parkinson\u2019s disease","volume":"15","author":"Pe\u00f1a-D\u00edaz","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib245","series-title":"Methods in neurodegenerative disease drug discovery","first-page":"61","article-title":"Identification of \u03b1-synuclein aggregation inhibitors via high-throughput screening","author":"Pe\u00f1a-D\u00edaz","year":"2024"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101902","article-title":"The small aromatic compound synuclean-D inhibits the aggregation and seeded polymerization of multiple \u03b1-synuclein strains","volume":"298","author":"Pe\u00f1a-D\u00edaz","year":"2022","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib247","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.4103\/1673-5374.284993","article-title":"Small molecules to prevent the neurodegeneration caused by \u03b1-synuclein aggregation","volume":"15","author":"Pena-Diaz","year":"2020","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib248","series-title":"Interplay between alpha-synuclein and oxidative stress in Parkinson\u00b4s disease cell models","author":"Perfeito","year":"2012"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib249","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1021\/acschembio.8b00466","article-title":"Multistep inhibition of \u03b1-synuclein aggregation and toxicity in vitro and in vivo by trodusquemine","volume":"13","author":"Perni","year":"2018","journal-title":"ACS Chemical Biology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib250","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","article-title":"A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity","volume":"114","author":"Perni","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib251","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbamem.2011.07.032","article-title":"Biophysics of \u03b1-synuclein membrane interactions","volume":"1818","author":"Pfefferkorn","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib252","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baad084","article-title":"aSynPEP-DB: A database of biogenic peptides for inhibiting \u03b1-synuclein aggregation","volume":"2023","author":"Pintado-Grima","year":"2023","journal-title":"Database"},{"issue":"5321","key":"10.1016\/bs.apcsb.2025.08.017_bib253","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110640","article-title":"Myricetin inhibits amyloid fibril formation of globular proteins by stabilizing the native structures","volume":"186","author":"Prajapati","year":"2020","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41531-023-00552-7","article-title":"In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson\u2019s disease","volume":"9","author":"Price","year":"2023","journal-title":"npj Parkinson's Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib256","doi-asserted-by":"crossref","first-page":"16165","DOI":"10.1038\/s41598-018-34490-9","article-title":"The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease","volume":"8","author":"Price","year":"2018","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib257","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel \u03b1-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"issue":"41","key":"10.1016\/bs.apcsb.2025.08.017_bib258","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1073\/pnas.1804198115","article-title":"Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons","volume":"115","author":"Pujols","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102474","article-title":"Lactoferrin\/lactoferrin receptor: Neurodegenerative or neuroprotective in Parkinson\u2019s disease?","author":"Qian","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuropharm.2018.09.042","article-title":"Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced \u03b1-synuclein aggregation","volume":"144","author":"Qu","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib261","doi-asserted-by":"crossref","first-page":"1204104","DOI":"10.3389\/fneur.2023.1204104","article-title":"Sex differences in alpha-synucleinopathies: A systematic review","volume":"14","author":"Raheel","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib262","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1039\/D0MA00760A","article-title":"Review of the current state of protein aggregation inhibition from a materials chemistry perspective: Special focus on polymeric materials","volume":"2","author":"Rajan","year":"2021","journal-title":"Materials Advances"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib263","series-title":"Mammalian cell models for investigating alpha-synuclein modulation of vesicle trafficking and interaction with mitochondria","author":"Ramezani","year":"2020"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib264","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/biom13101476","article-title":"The effects of lipids on \u03b1-synuclein aggregation in vitro","volume":"13","author":"Ramirez","year":"2023","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib265","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/acschemneuro.7b00149","article-title":"Perturbation in long-range contacts modulates the kinetics of amyloid formation in \u03b1-synuclein familial mutants","volume":"8","author":"Ranjan","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib266","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-023-02623-8","article-title":"Clinical benefit of MAO-B and COMT inhibition in Parkinson\u2019s disease: Practical considerations","volume":"130","author":"Regensburger","year":"2023","journal-title":"Journal of Neural Transmission"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib267","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac259","article-title":"Protein kinase r dependent phosphorylation of \u03b1-synuclein regulates its membrane binding and aggregation","volume":"1","author":"Reimer","year":"2022","journal-title":"PNAS Nexus"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib268","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","article-title":"Lewy bodies, iron, inflammation and neuromelanin: Pathological aspects underlying Parkinson\u2019s disease","volume":"130","author":"Riederer","year":"2023","journal-title":"Journal of Neural Transmission"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib269","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/MCB.22.6.1926-1935.2002","article-title":"BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore","volume":"22","author":"Risso","year":"2002","journal-title":"Molecular and Cellular Biology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062012","article-title":"Novel insulin sensitizer modulates nutrient sensing pathways and maintains \u03b2-cell phenotype in human islets","volume":"8","author":"Rohatgi","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib271","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/acschemneuro.6b00331","article-title":"Elucidating important sites and the mechanism for amyloid fibril formation by coarse-grained molecular dynamics","volume":"8","author":"Rojas","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib272","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41467-023-37561-2","article-title":"Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage","volume":"14","author":"Rosado-Ramos","year":"2023","journal-title":"Nature Communications"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.08.017_bib273","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1021\/acs.chemrev.1c00941","article-title":"Second sphere interactions in amyloidogenic diseases","volume":"122","author":"Roy","year":"2022","journal-title":"Chemical Reviews"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib274","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/acsnano.9b09676","article-title":"The influence of pathogenic mutations in \u03b1-synuclein on biophysical and structural characteristics of amyloid fibrils","volume":"14","author":"Ruggeri","year":"2020","journal-title":"ACS Nano"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.08.017_bib275","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1021\/acschemneuro.1c00379","article-title":"Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: Experimental findings and mechanistic insights from molecular dynamics simulation","volume":"12","author":"Saffari","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib276","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1021\/acsomega.8b00993","article-title":"Tuning the balance between fibrillation and oligomerization of \u03b1-synuclein in the presence of dopamine","volume":"3","author":"Saha","year":"2018","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib277","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/bi401543z","article-title":"Site-specific fluorescence dynamics of \u03b1-synuclein fibrils using time-resolved fluorescence studies: Effect of familial Parkinson\u2019s disease-associated mutations","volume":"53","author":"Sahay","year":"2014","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib278","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1074\/jbc.M114.598607","article-title":"Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of \u03b1-synuclein","volume":"290","author":"Sahay","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib279","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1389203717666160314151706","article-title":"Alteration of structure and aggregation of \u03b1-synuclein by familial Parkinson\u2019s disease associated mutations","volume":"18","author":"Sahay","year":"2017","journal-title":"Current Protein and Peptide Science"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib280","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijbiomac.2021.07.056","article-title":"Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies","volume":"186","author":"Salahuddin","year":"2021","journal-title":"International Journal of Biological Macromolecules"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib281","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(16)00060-0","article-title":"Challenges of modifying disease progression in prediagnostic Parkinson's disease","volume":"15","author":"Salat","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"1-3","key":"10.1016\/bs.apcsb.2025.08.017_bib282","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2010.02.004","article-title":"Protein kinetic stability","volume":"148","author":"Sanchez-Ruiz","year":"2010","journal-title":"Biophysical Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib283","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060006","article-title":"Conformational equilibria in monomeric \u03b1-synuclein at the single-molecule level","volume":"6","author":"Sandal","year":"2008","journal-title":"PLoS Biology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib284","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/metabo14070352","article-title":"Interaction between \u03b1-synuclein and bioactive lipids: Neurodegeneration, disease biomarkers and emerging therapies","volume":"14","author":"Sanluca","year":"2024","journal-title":"Metabolites"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.017_bib285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib286","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijbiomac.2019.09.053","article-title":"Natural compound safranal driven inhibition and dis-aggregation of \u03b1-synuclein fibrils","volume":"141","author":"Save","year":"2019","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib287","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-019-01104-1","article-title":"Targeting \u03b1-synuclein in Parkinson\u2019s disease: Progress towards the development of disease-modifying therapeutics","volume":"79","author":"Savitt","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib288","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1038\/s41598-019-47227-z","article-title":"Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for lewy body disorders","volume":"9","author":"Schaser","year":"2019","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib289","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/cr60307a001","article-title":"Nitrogen-containing compounds in tobacco and tobacco smoke","volume":"77","author":"Schmeltz","year":"1977","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathologica"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.08.017_bib291","doi-asserted-by":"crossref","first-page":"11198","DOI":"10.3390\/ijms252011198","article-title":"Small molecules, \u03b1-synuclein pathology, and the search for effective treatments in Parkinson\u2019s disease","volume":"25","author":"Sechi","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, tau, and \u03b1-synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Progress in Neurobiology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib293","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic \u03b1-synuclein filaments shows amyloid-like cross-\u03b2 conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib294","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/membranes14110231","article-title":"Modulation of biological membranes using Small-molecule compounds to counter toxicity caused by amyloidogenic proteins","volume":"14","author":"Seychell","year":"2024","journal-title":"Membranes"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013863","article-title":"Inhibiting \u03b1-synuclein oligomerization by stable cell-penetrating \u03b2-uclein fragments recovers phenotype of Parkinson's disease model flies","volume":"5","author":"Shaltiel-Karyo","year":"2010","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib296","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.jbchem.a003261","article-title":"Biophysical effect of amino acids on the prevention of protein aggregation","volume":"132","author":"Shiraki","year":"2002","journal-title":"The Journal of Biochemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib297","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1353-8020(02)00014-7","article-title":"Is there a connection between estrogen and Parkinson's disease?","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib298","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib299","doi-asserted-by":"crossref","DOI":"10.4081\/ams.2012.e3","article-title":"Protective effect of curcumin in transgenic drosophila melanogaster model of Parkinson\u2019s disease","volume":"2","author":"Siddique","year":"2012","journal-title":"Alternative Medicine Studies"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2015","journal-title":"Nutrition Journal"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib301","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1389200224666230608110349","article-title":"Structure of the blood brain barrier and its role in the transporters for the movement of substrates across the barriers","volume":"24","author":"Singh","year":"2023","journal-title":"Current Drug Metabolism"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib302","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib303","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108869","article-title":"Neurodegeneration: Impact of S-nitrosylated parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease","volume":"704","author":"Sircar","year":"2021","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib304","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1570159X13666151030103153","article-title":"Modulating the amyloidogenesis of \u03b1-synuclein","volume":"14","author":"Sivanesam","year":"2016","journal-title":"Current Neuropharmacology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.08.017_bib305","doi-asserted-by":"crossref","first-page":"11577","DOI":"10.1039\/C5RA00325C","article-title":"Binding interactions of agents that alter \u03b1-synuclein aggregation","volume":"5","author":"Sivanesam","year":"2015","journal-title":"RSC Advances"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.017_bib306","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/pharmaceutics15082051","article-title":"Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-synucleinopathy","volume":"15","author":"Siwecka","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib307","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/REVNEURO.1992.3.1.25","article-title":"Nicotine, Parkinson's and Alzheimer's disease","volume":"3","author":"Smith","year":"1992","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib308","doi-asserted-by":"crossref","unstructured":"Smith, H. L., Li, W., & Cheetham, M. E. (2015). Molecular chaperones and neuronal proteostasis. Paper presented at the Seminars in cell & developmental biology.","DOI":"10.1016\/j.semcdb.2015.03.003"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib309","first-page":"1","article-title":"Effect of reparation of repeat sequences in the human \u03b1-synuclein on fibrillation ability","volume":"3","author":"Sode","year":"2006","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib310","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The \u03b1\u2010synucleinopathies: Parkinson's disease, dementia with lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"6645","key":"10.1016\/bs.apcsb.2025.08.017_bib311","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib312","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson's disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib313","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: The interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib314","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","article-title":"The concept of alpha-synuclein as a prion-like protein: Ten years after","volume":"373","author":"Steiner","year":"2018","journal-title":"Cell Tissue Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib315","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/s41467-020-16564-3","article-title":"Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity","volume":"11","author":"Stephens","year":"2020","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib316","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/molecules27061776","article-title":"Amyloid cross-seeding: Mechanism, implication, and inhibition","volume":"27","author":"Subedi","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib317","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/bi901753h","article-title":"The clustering and spatial arrangement of \u03b2-sheet sequence, but not order, govern \u03b1-synuclein fibrillogenesis","volume":"49","author":"Suk","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101978","article-title":"Truncation or proteolysis of \u03b1-synuclein in parkinsonism","volume":"90","author":"Suthar","year":"2023","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: Implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib320","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000695","article-title":"Amyloidosis of the gastrointestinal tract and the liver: Clinical context, diagnosis and management","volume":"28","author":"Syed","year":"2016","journal-title":"European Journal of Gastroenterology Hepatology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib321","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/biom12040507","article-title":"\u03b1-Synuclein at the presynaptic axon terminal as a double-edged sword","volume":"12","author":"Tan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib322","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0310-y","article-title":"Fasudil attenuates aggregation of \u03b1-synuclein in models of Parkinson\u2019s disease","volume":"4","author":"Tatenhorst","year":"2016","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib323","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-7643-8340-4_6","article-title":"Heavy metal toxicity and the environment","author":"Tchounwou","year":"2012","journal-title":"Molecular, Clinical and Environmental Toxicology: Volume 3: Environmental Toxicology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib324","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/biom10030391","article-title":"Targeting \u03b1-synuclein for PD therapeutics: A pursuit on all fronts","volume":"10","author":"Teil","year":"2020","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib325","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cells12111486","article-title":"Sex and brain: The role of sex chromosomes and hormones in brain development and Parkinson\u2019s disease","volume":"12","author":"Terrin","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib326","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1212\/WNL.0000000000203774","article-title":"Small molecule inhibitors for precise inhibition of alpha-synuclein oligomer generation in Parkinson\u2019s disease (S32. 002)","volume":"100","author":"Thomson","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib327","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.947191","article-title":"The relationship of alpha-synuclein to mitochondrial dynamics and quality control","volume":"15","author":"Thorne","year":"2022","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib328","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-012369509-3.50019-6","article-title":"Polyglutamine disorders including Huntington\u2019s disease","author":"Todi","year":"2007","journal-title":"Molecular Neurology"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.017_bib329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:4:1-2:1","article-title":"Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses","volume":"4","author":"Trojanowski","year":"2003","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib330","series-title":"The flavonoids","first-page":"153","article-title":"Role of flavonoids in improving mental health","author":"Trushna","year":"2024"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.08.017_bib331","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib332","first-page":"86","article-title":"The effect of buffers on protein conformational stability","volume":"28","author":"Ugwu","year":"2004","journal-title":"Pharmaceutical Technology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib333","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00221-023-06765-9","article-title":"Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson\u2019s disease","volume":"242","author":"Ullah","year":"2024","journal-title":"Experimental Brain Research"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib334","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human \u03b1-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib335","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"BioMed Research International"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib336","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: Conformational plasticity of \u03b1-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"Journal of Biomolecular Structure Dynamics"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib337","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: Conformational plasticity of \u03b1-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"Journal of Biomolecular Structure Dynamics"},{"issue":"7-8","key":"10.1016\/bs.apcsb.2025.08.017_bib338","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijch.201600116","article-title":"\u03b1\u2010Synuclein oligomers: A study in diversity","volume":"57","author":"van Diggelen","year":"2017","journal-title":"Israel Journal of Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib339","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jmb.2009.10.021","article-title":"Tryptophan fluorescence reveals structural features of \u03b1-synuclein oligomers","volume":"394","author":"van Rooijen","year":"2009","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","article-title":"Synucleins have multiple effects on presynaptic architecture","volume":"18","author":"Vargas","year":"2017","journal-title":"Cell Reports"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib341","unstructured":"Vendruscolo, M., Chiti, F., Rinauro, D., & Limbocker, R. (2023). Misfolded protein oligomers: Mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases."},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib342","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.3390\/ijms25115906","article-title":"A comprehensive analytical review of polyphenols: Evaluating neuroprotection in Alzheimer\u2019s disease","volume":"25","author":"Vicente-Zurdo","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.017_bib343","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: Current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"issue":"25","key":"10.1016\/bs.apcsb.2025.08.017_bib344","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of \u03b1-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib345","unstructured":"Vittorio, S., De Luca, L., & Span\u00f2, N. (2021). Study and design of modulators of protein-protein interactions implicated in tumor and neurodegenerative diseases."},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib346","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00004691-200401000-00003","article-title":"Deep brain stimulation for the treatment of Parkinson\u2019s disease","volume":"21","author":"Volkmann","year":"2004","journal-title":"Journal of Clinical Neurophysiology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib347","unstructured":"Wagner, A. S. (2012). Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib348","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-015-1483-3","article-title":"Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies","volume":"130","author":"Wagner","year":"2015","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib349","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib350","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","article-title":"Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of lewy-type histopathology in human brains","volume":"240","author":"Walker","year":"2013","journal-title":"Experimental Neurology"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.017_bib351","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","article-title":"\u03b1-Synuclein multimers cluster synaptic vesicles and attenuate recycling","volume":"24","author":"Wang","year":"2014","journal-title":"Current Biology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib352","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-57","article-title":"Curcumin reduces \u03b1-synuclein induced cytotoxicity in Parkinson's disease cell model","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112647","article-title":"Involvement of molecular chaperone in protein-misfolding brain diseases","volume":"147","author":"Wankhede","year":"2022","journal-title":"Biomedicine Pharmacotherapy"},{"issue":"40","key":"10.1016\/bs.apcsb.2025.08.017_bib354","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1021\/bi900539p","article-title":"Characterization of hydrophobic residue requirements for \u03b1-synuclein fibrillization","volume":"48","author":"Waxman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib355","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00401-019-02023-x","article-title":"Depopulation of dense \u03b1-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson\u2019s disease model","volume":"138","author":"Wegrzynowicz","year":"2019","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib356","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/jps.21521","article-title":"Principles, approaches, and challenges for predicting protein aggregation rates and shelf life","volume":"98","author":"Weiss Iv","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib357","series-title":"The physiological function of synucleins","author":"Westphal","year":"2013"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib358","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","article-title":"Monomeric\u00a0synucleins generate membrane curvature","volume":"288","author":"Westphal","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.017_bib359","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1998.1640","article-title":"Folding of \u03b2-sheet membrane proteins: A hydrophobic hexapeptide model","volume":"277","author":"Wimley","year":"1998","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-023-00614-w","article-title":"Aggregate-prone brain regions in Parkinson\u2019s disease are rich in unique N-terminus \u03b1-synuclein conformers with high proteolysis susceptibility","volume":"10","author":"Wiseman","year":"2024","journal-title":"npj Parkinson's Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib361","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41419-022-05030-1","article-title":"p21-Activated kinase 4 controls the aggregation of \u03b1-synuclein by reducing the monomeric and aggregated forms of \u03b1-synuclein: Involvement of the E3 ubiquitin ligase NEDD4-1","volume":"13","author":"Won","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.017_bib362","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.017_bib363","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.3390\/molecules25173976","article-title":"Synergistic effects of ginkgolide B and protocatechuic acid on the treatment of Parkinson\u2019s disease","volume":"25","author":"Wu","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.08.017_bib364","doi-asserted-by":"crossref","first-page":"11275","DOI":"10.3390\/ijms241411275","article-title":"Targeting protein aggregates with natural products: An optional strategy for neurodegenerative diseases","volume":"24","author":"Xiang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib365","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","article-title":"Alpha-synuclein and protein degradation systems: A reciprocal relationship","volume":"47","author":"Xilouri","year":"2013","journal-title":"Molecular Neurobiology"},{"issue":"34","key":"10.1016\/bs.apcsb.2025.08.017_bib366","doi-asserted-by":"crossref","first-page":"30281","DOI":"10.1021\/acsomega.2c03534","article-title":"Curcumin interacts with \u03b1-synuclein condensates to inhibit amyloid aggregation under phase separation","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Omega"},{"issue":"16","key":"10.1016\/bs.apcsb.2025.08.017_bib367","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200216","article-title":"Myricetin inhibits \u03b1\u2010synuclein amyloid aggregation by delaying the liquid\u2010to\u2010solid phase transition","volume":"23","author":"Xu","year":"2022","journal-title":"Chembiochem: a European Journal of Chemical Biology"},{"issue":"37","key":"10.1016\/bs.apcsb.2025.08.017_bib368","doi-asserted-by":"crossref","first-page":"12447","DOI":"10.1021\/jp903106x","article-title":"Cross-\u03b2-sheet structure in amyloid fiber formation","volume":"113","author":"Xu","year":"2009","journal-title":"The Journal of Physical Chemistry. B"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib369","doi-asserted-by":"crossref","first-page":"1149963","DOI":"10.3389\/fneur.2023.1149963","article-title":"Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis","volume":"14","author":"Xu","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.017_bib370","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.prp.2014.02.005","article-title":"Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat","volume":"210","author":"Yang","year":"2014","journal-title":"Pathology-Research and Practice"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib371","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1038\/s41598-017-18349-z","article-title":"EGCG-mediated protection of the membrane disruption and cytotoxicity caused by the \u2018active oligomer\u2019of \u03b1-synuclein","volume":"7","author":"Yang","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib372","article-title":"The potential of natural products to inhibit abnormal aggregation of \u03b1-synuclein in the treatment of Parkinson\u2019s disease","volume":"15","author":"Yang","year":"2024","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib373","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.959425","article-title":"Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions","volume":"9","author":"Yoo","year":"2022","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib374","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.05.022","article-title":"Homozygous alpha-synuclein p. A53v in familial Parkinson's disease","volume":"57","author":"Yoshino","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib375","series-title":"StatPearls [Internet]","article-title":"Neuroanatomy, basal ganglia","author":"Young","year":"2023"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.017_bib376","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/acschemneuro.3c00617","article-title":"Rapid FRET assay for the early detection of alpha-synuclein aggregation in Parkinson\u2019s disease","volume":"15","author":"Yu","year":"2024","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib377","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10565-017-9419-4","article-title":"Ginkgolide k promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells","volume":"34","author":"Yu","year":"2018","journal-title":"Cell Biology Toxicology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.017_bib378","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1111\/ejn.16160","article-title":"The function of astrocytes and their role in neurological diseases","volume":"58","author":"Yuan","year":"2023","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib379","first-page":"3362","article-title":"Amyloid-fibril formation","volume":"269","author":"Z\u02c7erovnik","year":"2002","journal-title":"European Journal of Biochemistry \/ FEBS"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.017_bib380","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-018-0054-4","article-title":"Genetic fine-mapping of the iowan SNCA gene triplication in a patient with Parkinson\u2019s disease","volume":"4","author":"Zafar","year":"2018","journal-title":"npj Parkinson's Disease"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.017_bib381","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1080\/07391102.2020.1860824","article-title":"Two polyphenols with diverse mechanisms towards amyloidosis: Differential modulation of the fibrillation pathway of human lysozyme by curcumin and EGCG","volume":"40","author":"Zaidi","year":"2022","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.017_bib382","first-page":"164","article-title":"The new mutation, E46K, of \u03b1\u2010synuclein causes parkinson and lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Journal of the American Neurological Association the Child Neurology Society"},{"key":"10.1016\/bs.apcsb.2025.08.017_bib383","unstructured":"Zhang, B. (2021). Regulation of copper homeostasis by the ubiquitin proteasome system."},{"key":"10.1016\/bs.apcsb.2025.08.017_bib384","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnagi.2018.00370","article-title":"New perspectives on roles of alpha-synuclein in Parkinson\u2019s disease","volume":"10","author":"Zhang","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"52","key":"10.1016\/bs.apcsb.2025.08.017_bib385","doi-asserted-by":"crossref","first-page":"32508","DOI":"10.1039\/C7RA03752J","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"RSC Advances"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib386","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chemical Reviews"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib387","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmb.2009.03.053","article-title":"At low concentrations, 3, 4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to \u03b1-synuclein and prevents its fibrillation","volume":"388","author":"Zhou","year":"2009","journal-title":"Journal of Molecular Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.017_bib388","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbadis.2009.12.004","article-title":"Methionine oxidation stabilizes non-toxic oligomers of \u03b1-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions","volume":"1802","author":"Zhou","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.017_bib389","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.bbagen.2012.12.027","article-title":"Oxidized quercetin inhibits \u03b1-synuclein fibrillization","volume":"1830","author":"Zhu","year":"2013","journal-title":"Biochimica et Biophysica Acta -General Subjects"},{"issue":"39","key":"10.1016\/bs.apcsb.2025.08.017_bib390","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1021\/acs.jpcb.7b08652","article-title":"Orcein-related small molecule O4 destabilizes hIAPP protofibrils by interacting mostly with the amyloidogenic core region","volume":"121","author":"Zou","year":"2017","journal-title":"The Journal of Physical Chemistry. B"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Protein Misfolding Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:49:32Z","timestamp":1764092972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443294143"],"references-count":390,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.08.017","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}